ArticlePathology oncology research : POR2024

Development, testing and validation of a targeted NGS-panel for the detection of actionable mutations in lung cancer (NSCLC) using anchored multiplex PCR technology in a multicentric setting.

Jörg Kumbrink et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.